Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation.

Abstract:

:In lymphocytes, the second messenger cyclic adenosine monophosphate (cAMP) plays a well-established antiproliferative role through inhibition of G(1)/S transition and S-phase progression. We have previously demonstrated that, during S-phase arrest, cAMP inhibits the action of S phase-specific cytotoxic compounds, leading to reduction in their apoptotic response. In this report, we provide evidence that cAMP can also inhibit the action of DNA-damaging agents independently of its effect on S phase. Elevation of cAMP in B-cell precursor acute lymphoblastic leukemia cells is shown to profoundly inhibit the apoptotic response to ionizing radiation, anthracyclins, alkylating agents, and platinum compounds. We further demonstrate that this effect depends on the ability of elevated cAMP levels to quench DNA damage-induced p53 accumulation by increasing the p53 turnover, resulting in attenuated Puma and Bax induction, mitochondrial outer membrane depolarization, caspase activation, and poly(ADP-ribose) polymerase cleavage. On the basis of our findings, we suggest that cAMP levels may influence p53 function in malignant cells that retain wild-type p53, potentially affecting p53 both as a tumor suppressor during cancer initiation and maintenance, and as an effector of the apoptotic response to DNA-damaging agents during anticancer treatment.

journal_name

Blood

journal_title

Blood

authors

Naderi EH,Findley HW,Ruud E,Blomhoff HK,Naderi S

doi

10.1182/blood-2009-02-204883

subject

Has Abstract

pub_date

2009-07-16 00:00:00

pages

608-18

issue

3

eissn

0006-4971

issn

1528-0020

pii

blood-2009-02-204883

journal_volume

114

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3.

    abstract::The Wrb antigen is a high-frequency human erythrocyte antigen invariably absent from En (a-) erythrocytes, which lack glycophorin A. However, glycophorin A from En (a+) Wr (a+b-) red cells has an amino acid sequence identical to that of glycophorin A from Wr (b+) erythrocytes. Evidence has suggested that the Wrb antig...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Telen MJ,Chasis JA

    更新日期:1990-08-15 00:00:00

  • A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.

    abstract::BB-10010 is a variant of the human form of macrophage inflammatory protein-1alpha (MIP-1alpha), which has been shown in mice to block the entry of hematopoietic stem cells into S-phase and to increase their self-renewal capacity during recovery from cytotoxic damage. Its use may constitute a novel approach for protect...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Clemons MJ,Marshall E,Dürig J,Watanabe K,Howell A,Miles D,Earl H,Kiernan J,Griffiths A,Towlson K,DeTakats P,Testa NG,Dougal M,Hunter MG,Wood LM,Czaplewski LG,Millar A,Dexter TM,Lord BI

    更新日期:1998-09-01 00:00:00

  • Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

    abstract::Strategies that augment a GVL effect without increasing the risk of GVHD are required to improve the outcome after allogeneic stem cell transplantation (SCT). Azacitidine (AZA) up-regulates the expression of tumor Ags on leukemic blasts in vitro and expands the numbers of immunomodulatory T regulatory cells (Tregs) in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-377044

    authors: Goodyear OC,Dennis M,Jilani NY,Loke J,Siddique S,Ryan G,Nunnick J,Khanum R,Raghavan M,Cook M,Snowden JA,Griffiths M,Russell N,Yin J,Crawley C,Cook G,Vyas P,Moss P,Malladi R,Craddock CF

    更新日期:2012-04-05 00:00:00

  • Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.

    abstract::Production of a red blood cell's hemoglobin depends on mitochondrial heme synthesis. However, mature red blood cells are devoid of mitochondria and rely on glycolysis for ATP production. The molecular basis for the selective elimination of mitochondria from mature red blood cells remains controversial. Recent evidence...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-137398

    authors: Kundu M,Lindsten T,Yang CY,Wu J,Zhao F,Zhang J,Selak MA,Ney PA,Thompson CB

    更新日期:2008-08-15 00:00:00

  • Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells.

    abstract::The effects of activation of adult murine stem cells on their expression of CD38 were studied using a murine transplantation model. First, the published finding that the majority of long-term engrafting cells from normal adult steady-state marrow are CD38(+) was confirmed. Next, it was determined that the majority of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.9.2618

    authors: Tajima F,Deguchi T,Laver JH,Zeng H,Ogawa M

    更新日期:2001-05-01 00:00:00

  • Perturbed hematopoiesis in mice lacking ATMIN.

    abstract::The ataxia telangiectasia mutated (ATM)-interacting protein ATMIN mediates noncanonical ATM signaling in response to oxidative and replicative stress conditions. Like ATM, ATMIN can function as a tumor suppressor in the hematopoietic system: deletion of Atmin under the control of CD19-Cre results in B-cell lymphomas i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672980

    authors: Anjos-Afonso F,Loizou JI,Bradburn A,Kanu N,Purewal S,Da Costa C,Bonnet D,Behrens A

    更新日期:2016-10-20 00:00:00

  • A specific stimulator of granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in the mouse.

    abstract::We have identified a small molecular weight compound, SCH 14988, which specifically stimulates in vitro granulocyte-colony stimulating factor (G-CSF) production from activated human peripheral blood mononuclear cells and monocytes but not other cytokines or CSFs with hematoregulatory activity. In vivo administration o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fine JS,Cai XY,Justice L,Gommoll CP Jr,Hamilton LD,Waters TA,Narula SK,Bober LA,Grace MJ

    更新日期:1997-07-15 00:00:00

  • Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

    abstract::Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of abnormal lymphocyte survival caused by defective Fas-mediated apoptosis, leading to lymphadenopathy, hepatosplenomegaly, and an increased number of double-negative T cells (DNTs). Treatment options for patients with ALPS are limited. Rapamycin has been sh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-01-010124

    authors: Teachey DT,Obzut DA,Axsom K,Choi JK,Goldsmith KC,Hall J,Hulitt J,Manno CS,Maris JM,Rhodin N,Sullivan KE,Brown VI,Grupp SA

    更新日期:2006-09-15 00:00:00

  • Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives.

    abstract::Conflicting data have been reported on the risk for venous thrombosis in subjects with low free protein S levels. We performed a post-hoc analysis in a single-center retrospective thrombophilic family cohort, to define the optimal free protein S level that can identify subjects at risk for venous thrombosis. Relatives...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2008-08-174128

    authors: Lijfering WM,Mulder R,ten Kate MK,Veeger NJ,Mulder AB,van der Meer J

    更新日期:2009-02-05 00:00:00

  • Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

    abstract::Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363390

    authors: Betts BC,St Angelo ET,Kennedy M,Young JW

    更新日期:2011-11-10 00:00:00

  • Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreading.

    abstract::Plasmin cleaves fibrin at or near sites involved in platelet recognition and may modulate platelet adhesion and spreading. Using an in vitro system, we have characterized the effects of limited plasmic degradation of polymerized fibrin on platelet adhesion and spreading. As shown by scanning electron microscopy, expos...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamaguchi M,Bunce LA,Sporn LA,Francis CW

    更新日期:1994-08-15 00:00:00

  • Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency.

    abstract::Fibrillar collagens are among the most potent activators of platelets and play an important role in the initiation of thrombosis. The glycoprotein VI (GPVI)/FcRgamma-chain complex is a central collagen receptor and inhibitors of GPVI produce a major defect in arterial thrombogenesis. In this study we have examined art...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4244

    authors: Mangin P,Yap CL,Nonne C,Sturgeon SA,Goncalves I,Yuan Y,Schoenwaelder SM,Wright CE,Lanza F,Jackson SP

    更新日期:2006-06-01 00:00:00

  • Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities.

    abstract::Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several hematologic malignancies, most notably B-cell non-Hodgkin lymphoma (NHL). In this review we summarize this evidence, address possible mechanisms whereby hepatitis vir...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-06-275818

    authors: Marcucci F,Mele A

    更新日期:2011-02-10 00:00:00

  • Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.

    abstract::Mutations in a recently identified gene HJV (also called HFE2, or repulsive guidance molecule C, RgmC) are the major cause of juvenile hemochromatosis (JH). The protein product of HJV, hemojuvelin, contains a C-terminal glycosylphosphatidylinositol anchor, suggesting that it can be present in either a soluble or a cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-1845

    authors: Lin L,Goldberg YP,Ganz T

    更新日期:2005-10-15 00:00:00

  • Vascular remodeling of the vitelline artery initiates extravascular emergence of hematopoietic clusters.

    abstract::The vitelline artery is a temporary structure that undergoes extensive remodeling during midgestation to eventually become the superior mesenteric artery (also called the cranial mesenteric artery, in the mouse). Here we show that, during this remodeling process, large clusters of hematopoietic progenitors emerge via ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279497

    authors: Zovein AC,Turlo KA,Ponec RM,Lynch MR,Chen KC,Hofmann JJ,Cox TC,Gasson JC,Iruela-Arispe ML

    更新日期:2010-11-04 00:00:00

  • Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

    abstract::In a previous multicenter phase III trial comparing peripheral blood stem cell transplantation (PBSCT) to bone marrow transplantation (BMT) from HLA-matched related donors, we found no statistically significant difference in the cumulative incidence of clinical extensive chronic graft-versus-host disease (GVHD) in the...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2002-01-0011

    authors: Flowers ME,Parker PM,Johnston LJ,Matos AV,Storer B,Bensinger WI,Storb R,Appelbaum FR,Forman SJ,Blume KG,Martin PJ

    更新日期:2002-07-15 00:00:00

  • A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

    abstract::We report a novel t(7;9)(q11;p13) translocation in 2 patients with B-cell acute lymphoblastic leukemia (B-ALL). By fluorescent in situ hybridization and 3' rapid amplification of cDNA ends, we showed that the paired box domain of PAX5 was fused with the elastin (ELN) gene. After cloning the full-length cDNA of the chi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-025221

    authors: Bousquet M,Broccardo C,Quelen C,Meggetto F,Kuhlein E,Delsol G,Dastugue N,Brousset P

    更新日期:2007-04-15 00:00:00

  • Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

    abstract::Adenovirus-transduced CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (CD34-TRAIL+ cells) exert potent antitumor activity. To further investigate the mechanism(s) of action of CD34-TRAIL+ cells, we analyzed their homing properties as well as antitumor and antivascular effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-239632

    authors: Lavazza C,Carlo-Stella C,Giacomini A,Cleris L,Righi M,Sia D,Di Nicola M,Magni M,Longoni P,Milanesi M,Francolini M,Gloghini A,Carbone A,Formelli F,Gianni AM

    更新日期:2010-03-18 00:00:00

  • CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency.

    abstract::CTLA-4 is a critical inhibitory "checkpoint" molecule of immune activation. Several recent reports have described patients with immune dysregulation and lymphoproliferative disease resulting from 2 different genetic diseases that directly or indirectly cause CTLA-4 deficiency. Numerous articles have also been publishe...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-04-712612

    authors: Lo B,Fritz JM,Su HC,Uzel G,Jordan MB,Lenardo MJ

    更新日期:2016-08-25 00:00:00

  • Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes.

    abstract::Human megakaryocyte differentiation and maturation were studied in fresh marrow aspirates by using multiparameter flow cytometric correlative analysis. The expression of glycoprotein (GP)IIb/IIIa, GPIIIa, GPIb, and CD36 correlated directly with cell size and ploidy (r > 0.97); however, GPIb acquisition was relatively ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0769

    authors: Tomer A

    更新日期:2004-11-01 00:00:00

  • The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.

    abstract::Gene transfer in human hematopoietic stem cells (HSCs) has great potential for both gene therapy and the understanding of hematopoiesis. As HSCs have extensive proliferative capacities, stable gene transfer should include genomic integration of the transgene. Lentiviral vectors are now preferred to oncoretroviral vect...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sirven A,Pflumio F,Zennou V,Titeux M,Vainchenker W,Coulombel L,Dubart-Kupperschmitt A,Charneau P

    更新日期:2000-12-15 00:00:00

  • The interphase microtubule damage checkpoint defines an S-phase commitment point and does not require p21(waf-1).

    abstract::Cell cycle checkpoints ensure orderly progression of events during cell division. A microtubule damage (MTD)-induced checkpoint has been described in G(1) phase of the cell cycle (G(1)MTC) for which little is known. The present study shows that the G(1)MTC is intact in activated T lymphocytes from mice with the p21(wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.5.1505

    authors: Mantel CR,Braun SE,Lee Y,Kim YJ,Broxmeyer HE

    更新日期:2001-03-01 00:00:00

  • Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells.

    abstract::Down-regulation of immune responses by regulatory T (Treg) cells is an important mechanism involved in the induction of tolerance to allo-antigens (Ags). Recently, a novel subset of Ag-specific T-cell receptor (TCR)alpha beta+ CD4(-)CD8- (double-negative [DN]) Treg cells has been found to be able to prevent the reject...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2583

    authors: Fischer K,Voelkl S,Heymann J,Przybylski GK,Mondal K,Laumer M,Kunz-Schughart L,Schmidt CA,Andreesen R,Mackensen A

    更新日期:2005-04-01 00:00:00

  • Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

    abstract::The present study focuses on a large family with an X-linked immunodeficiency in which there are variable clinical and laboratory phenotypes, including recurrent viral and bacterial infections, hypogammaglobulinemia, Epstein-Barr virus-driven lymphoproliferation, splenomegaly, colitis, and liver disease. Molecular and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-328849

    authors: Rigaud S,Lopez-Granados E,Sibéril S,Gloire G,Lambert N,Lenoir C,Synaeve C,Stacey M,Fugger L,Stephan JL,Fischer A,Picard C,Durandy A,Chapel H,Latour S

    更新日期:2011-07-14 00:00:00

  • A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

    abstract::The cause of immune thrombocytopenia (ITP) remains unknown. Studies have suggested immunizations as possible triggering factors of ITP through molecular mimicry. This case-control study explored potential associations between adult ITP and various routinely administered vaccines. A network of internal medicine and hem...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2012-05-431098

    authors: Grimaldi-Bensouda L,Michel M,Aubrun E,Leighton P,Viallard JF,Adoue D,Magy-Bertrand N,Tisserand G,Khellaf M,Durand JM,Quittet P,Fain O,Bonnotte B,Morin AS,Limal N,Costedoat-Chalumeau N,Morel N,Pan-Petesch B,Decaux O,

    更新日期:2012-12-13 00:00:00

  • Heterogeneity in human prothrombin: analysis of cause.

    abstract::Two fractions of human prothrombin can be isolated from single donor plasma by the technique of heparin-agarose chromatography in (sodium) citrate buffer, pH 7.5, as previously reported for pooled plasma. The two fractions, designated H-II1 and H-II2, are found in a ratio of approximately 4:1. Both forms comigrate in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bajaj SP,Rapaport SI,Prodonos C,Russell WA

    更新日期:1981-11-01 00:00:00

  • Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

    abstract::Antigens implicated in the graft-versus-leukemia (GVL) effect in chronic myeloid leukemia (CML) include WT1, PR1, and BCR-ABL. To detect very low frequencies of these antigen-specific CD8+ T cells, we used quantitative polymerase chain reaction (qPCR) to measure interferon-gamma (IFN-gamma) mRNA production by peptide-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0150

    authors: Rezvani K,Grube M,Brenchley JM,Sconocchia G,Fujiwara H,Price DA,Gostick E,Yamada K,Melenhorst J,Childs R,Hensel N,Douek DC,Barrett AJ

    更新日期:2003-10-15 00:00:00

  • Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

    abstract::Patients with relapsed chronic lymphocytic leukemia (CLL) and high-risk features, such as fludarabine refractoriness, complex karyotype, or abnormalities of chromosome 17p, experience poor outcomes after standard fludaradine-based regimens. Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341032

    authors: Badoux XC,Keating MJ,Wang X,O'Brien SM,Ferrajoli A,Faderl S,Burger J,Koller C,Lerner S,Kantarjian H,Wierda WG

    更新日期:2011-08-25 00:00:00

  • Transplant survivorship: a call to arms.

    abstract::In this issue of Blood, Sun and colleagues from the Bone Marrow Transplant Survivors Study report the chronic health outcomes of more than 1000 survivors of stem cell transplantation. Their results demonstrate a significant burden of chronic conditions among survivors. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2010-08-299420

    authors: Cutler C

    更新日期:2010-10-28 00:00:00

  • Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis.

    abstract::Cyclic adenosine monophosphate (cAMP) is an important modulator of platelet responses to agonists. Cyclic nucleotide phosphodiesterase (PDE) controls intracellular cAMP concentrations by hydrolyzing it to AMP. The major PDE activity in platelets is PDE3A (cyclic guanosine monophosphate [cGMP]-inhibited PDE). To obtain...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cheung PP,Xu H,McLaughlin MM,Ghazaleh FA,Livi GP,Colman RW

    更新日期:1996-08-15 00:00:00